The first line of treatment for skin carcinomas and melanoma is removing the cancerous growth. Early diagnosis and medical treatment are associated with improved outlooks for all cancer types.
The FDA has approved cosibelimab (marketed under the brand name Unloxcyt), a new drug for adults with advanced cutaneous squamous cell carcinoma (CSCC), a type of skin cancer.